Institute of Nanotechnology

Autor: Krzysztof Hübner <hubner_at_iod.krakow.pl>
Data: Wed 28 Nov 2007 - 08:12:35 MET
Message-ID: <001a01c8318e$0d9ae070$041d9c95@kh002007>
Content-Type: multipart/alternative; boundary="----=_NextPart_000_0017_01C83196.6EFDA070"

The Institute of Nanotechnology, global leaders in nanotechnology information services, is organising its second annual nanomedicine conference and exhibition 'Investing in Medical Nanotechnology II', which will showcase the latest developments in nanomedicine and potential routes to financing. The two day event will see leading multinational companies such as Philips, AstraZeneca, GE Healthcare, GlaxoSmithKline, Volcano Corporation and Fresenius Medical Care sharing their vision on the impacts of nanomedicine on healthcare and providing a window on their activities in the area. The conference will also see top industry figures offering their views on how to manage 'risks and uncertainties' as well as the challenges in integrating nanomedicine into established pharmaceutical and medical device business models.

 http://www.nano.org.uk/index.htm
Received on Wed Nov 28 08:12:38 2007

To archiwum zostało wygenerowane przez hypermail 2.1.8 : Wed 28 Nov 2007 - 09:03:08 MET